About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Immunodeficiency in MS | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04447937

Immunodeficiency in MS

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.

Lead sponsor: Advanced Neurosciences Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Samuel F Hunter, MD, PhD

CONTACT

6157915470 sfhunter@neurosci.us

Julia G Dickenson, BS, BA

CONTACT

6157915470 jgdickenson@neurosci.us

Sponsors

Lead Sponsor

Advanced Neurosciences Institute

Collaborators

Novel Pharmaceutics Institute

The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS. By understanding this relationship future studies can be designed to create a model of immunosenescence in multiple sclerosis, which could help healthcare providers to predict and assess health risks. Preventative strategies can then be tested to look for ways to prevent these immune-related risks.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•One or more immunoglobulin level results and medical history available
•18 years of age or older at the time of data collection
•Patients with first symptom MS or other isolated demyelinating syndromes, neuromyelitis optica, or rheumatic-associated CNS inflammation

Exclusion Criteria

•No evidence of CNS autoimmune disease
•Less than 18 years of age at the time of data abstraction
•Undergoing plasma exchange at the time of any lab tests drawn

Related studies

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

RECRUITINGPhase 2

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

RECRUITINGPhase 3

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 25, 2020Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,500

Start dateJun 2020

Last updatedJun 25, 2020

Condition

Multiple Sclerosis Hypogammaglobulinemia Immunodeficiency Infection, Bacterial

Locations shown

Advanced Neurosciences Institute

Franklin, Tennessee

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions